Additional Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Charleston, SC
    Charleston SC. 29425
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Salt Lake City, UT
    Salt Lake City UT. 84103
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Ann Arbor, MI
    Ann Arbor MI. 48209
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Nashville, TN
    Nashville TN. 37204
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Durham, NC
    Durham NC. 27710
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Denver, CO
    Denver CO. 80206
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Wilwaukee, WI
    Milwaukee WI. 52226
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Calgary, Alberta
    Calgary AB. T2N 4Z5
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Los Angeles, CA
    Los Angeles CA. 90033
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Birmingham, AL
    Birmingham AL. 35233
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Baltimore, MD
    Baltimore MD. 21224
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Detroit, MI
    Detroit MI. 48202
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Trois-Rivières, Quebec
    Trois-Rivières QC. G8T 7A1
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Kansas City, KS
    Kansas City KS. 66160
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Dallas, TX
    Dallas TX. 75204
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Oklahoma City, OK
    Oklahoma City OK. 73104
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in New York, NY
    New York NY. 10032
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Loxahatchee, FL
    Loxahatchee Groves FL. 33470
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Palm Springs, CA
    Palm Springs CA. 92203
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Greensboro, NC
    Greensboro NC. 27403
    View Details